KR840008367A - 악타플라닌 항생물질의 제조방법 - Google Patents
악타플라닌 항생물질의 제조방법 Download PDFInfo
- Publication number
- KR840008367A KR840008367A KR1019840002239A KR840002239A KR840008367A KR 840008367 A KR840008367 A KR 840008367A KR 1019840002239 A KR1019840002239 A KR 1019840002239A KR 840002239 A KR840002239 A KR 840002239A KR 840008367 A KR840008367 A KR 840008367A
- Authority
- KR
- South Korea
- Prior art keywords
- hydrogen
- acttaplanin
- antibiotic
- preparing
- glucosyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
- C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/19—Antibiotic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/27—Cyclic peptide or cyclic protein
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (1)
- 인자 A, B1, B2, B3, C1a, C3및 G로 이루어진 그룹에서 선택된 적절한 악타플라닌 인자를 80내지 100℃의 온도 및 1.5내지 2.0의 pH에서 부분적으로 가수분해시킴을 특징으로 하여 다음 일반식(I)의 화합물 및 그의 약학적으로 허용되는 염을 제조하는 방법.상기식에서, R은 L-리스토아민이고; R1은 수소, 글루코실, 또는 디사카라이드 만노실-글루코스 또는 람노실-글루코스이며; R2및 R3는 각각 수소 또는 만노스이다. (단 R1이 수소이면 R2나 R3중의 하나 또는 둘다 만노스이고; R1이 글루코실이면 R2및 R3는 둘다 수소이며; R1이 디사카라이드면 R2는 수소이다).※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US488967 | 1983-04-27 | ||
US06/488,967 US4479897A (en) | 1983-04-27 | 1983-04-27 | Actaplanin antibiotics |
Publications (2)
Publication Number | Publication Date |
---|---|
KR840008367A true KR840008367A (ko) | 1984-12-14 |
KR880000133B1 KR880000133B1 (ko) | 1988-03-12 |
Family
ID=23941856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019840002239A KR880000133B1 (ko) | 1983-04-27 | 1984-04-26 | 악타플라닌 항생물질의 제조방법 |
Country Status (9)
Country | Link |
---|---|
US (1) | US4479897A (ko) |
EP (1) | EP0124343A1 (ko) |
JP (1) | JPS59205392A (ko) |
KR (1) | KR880000133B1 (ko) |
DK (1) | DK210284A (ko) |
GB (1) | GB2138822B (ko) |
GR (1) | GR79574B (ko) |
HU (1) | HU189869B (ko) |
IL (1) | IL71625A0 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8307847D0 (en) * | 1983-03-22 | 1983-04-27 | Lepetit Spa | Antibiotics l 17054 and l 17046 |
US4558036A (en) * | 1984-02-17 | 1985-12-10 | Eli Lilly And Company | Actaplanin antibiotics |
US4547488A (en) * | 1984-04-16 | 1985-10-15 | Eli Lilly And Company | Antibiotic M43D, pharmaceutical compositions and method of use |
EP0368949A1 (en) * | 1988-02-10 | 1990-05-23 | Beecham Group Plc | Novel antibiotic compounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3952095A (en) * | 1972-06-02 | 1976-04-20 | Eli Lilly And Company | Novel antibiotic and a process for the production thereof |
US3928571A (en) * | 1972-12-15 | 1975-12-23 | Lilly Co Eli | Ruminant feed utilization improvement |
US4064233A (en) * | 1974-12-17 | 1977-12-20 | Eli Lilly And Company | Antibiotic A-4696 |
US4115552A (en) * | 1976-04-19 | 1978-09-19 | Eli Lilly And Company | Factor A and B of antibiotic A-4696 |
US4322406A (en) * | 1980-12-18 | 1982-03-30 | Eli Lilly And Company | Antibiotic A-4696 factors B1, B2, B3, C1a, C3 and E1 |
IL64486A (en) * | 1980-12-18 | 1985-01-31 | Lilly Co Eli | Antibiotic a-4696 factor g,its preparation and use as feed supplement for ruminant animals |
US4322343A (en) * | 1980-12-18 | 1982-03-30 | Eli Lilly And Company | Pseudo-aglycone of actaplanin |
-
1983
- 1983-04-27 US US06/488,967 patent/US4479897A/en not_active Expired - Fee Related
-
1984
- 1984-04-25 EP EP84302779A patent/EP0124343A1/en not_active Withdrawn
- 1984-04-25 IL IL71625A patent/IL71625A0/xx unknown
- 1984-04-25 GB GB08410585A patent/GB2138822B/en not_active Expired
- 1984-04-26 GR GR74510A patent/GR79574B/el unknown
- 1984-04-26 JP JP59086015A patent/JPS59205392A/ja active Pending
- 1984-04-26 HU HU841620A patent/HU189869B/hu unknown
- 1984-04-26 KR KR1019840002239A patent/KR880000133B1/ko active IP Right Grant
- 1984-04-26 DK DK210284A patent/DK210284A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR880000133B1 (ko) | 1988-03-12 |
GB8410585D0 (en) | 1984-05-31 |
JPS59205392A (ja) | 1984-11-20 |
GB2138822B (en) | 1986-08-28 |
GR79574B (ko) | 1984-10-30 |
HUT34043A (en) | 1985-01-28 |
US4479897A (en) | 1984-10-30 |
IL71625A0 (en) | 1984-07-31 |
DK210284D0 (da) | 1984-04-26 |
EP0124343A1 (en) | 1984-11-07 |
DK210284A (da) | 1984-10-28 |
GB2138822A (en) | 1984-10-31 |
HU189869B (en) | 1986-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR830007077A (ko) | 악타플라닌의 가비당체의 제조방법 | |
KR870002125A (ko) | 피리딘 유도체의 제조방법 | |
KR860007281A (ko) | 에리트로마이신 a 유도체의 선택적인 메틸화 방법 | |
KR860001110A (ko) | 항균제 ⅱ의 제법 | |
KR850004111A (ko) | 페노바비탈 및 카밤아제핀 공액체의 제조방법 | |
KR840005083A (ko) | 항고혈압제로서 유용한 아미노산유도체의 제조방법 | |
KR850000406A (ko) | 4-클로로-2-페닐이미다졸-5-아세트산유도체의 제조방법 | |
KR850006386A (ko) | 아졸류의 제조방법 | |
KR830000215A (ko) | 펩타이드 유도체의 제법 | |
ES470428A1 (es) | Un metodo de preparacion de compuestos heterociclicos deri- vados de hidantoina | |
KR830006198A (ko) | 시클로헥산 유도체의 제조방법 | |
KR840008367A (ko) | 악타플라닌 항생물질의 제조방법 | |
BG43867A3 (en) | Method for preparing of 6- alpha- methylcorticoids | |
KR850003411A (ko) | 글리코펩타이드 바이오컨버전 생성물의 제조방법 | |
KR850008492A (ko) | 트랜스, 트랜스-8,10-도데카디엔-1-일옥시실란의 제조방법 | |
KR920009792A (ko) | 3-아미노-4-메틸렌피롤리딘 유도체의 제조방법 | |
GB1419213A (en) | Acylurea compounds and their use | |
KR910011788A (ko) | 피리딘-n-옥사이드 유도체 및 이의 제조방법 | |
JPS5334988A (en) | Aminocyclitol derivative and its preparation | |
KR840000503A (ko) | 4-벤조일-5-히드록시 피라졸계 화합물의 제조방법 | |
FI841240A0 (fi) | Foerbaettringar i makrolidantibiotika. | |
KR870002061A (ko) | 페닐렌기를 가지는 스페르구알린계 화합물의 제조 방법 | |
KR860004008A (ko) | 부타놀유도체의 제법 | |
KR850005450A (ko) | N-포스포릴-또는 n-티오포스포릴-n'-s-트리아지닐-포름아미딘의 제조방법 | |
KR830003452A (ko) | 2-치환-4-티아졸리돈의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
NORF | Unpaid initial registration fee |